跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doxofix - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Doxofix
Approved
STANDARD
Doxofix
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
79c649f6b183dcc2
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
79c649f6b183dcc2
Drug Approval Philippines Name
Doxofix
Product Name
Doxofix
Registration Number
DR-XY43496
Brand Name
Doxofix
Generic Name
Doxofylline
Dosage Form
Tablet
Dosage Strength
400 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
25 July 2024
Expiry Date
15 July 2029
Pharmacologic Category
Anti-asthma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
79c649f6b183dcc2
Type
Standard
Back to Philippines FDA Approvals